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Much is still not understood regarding mechanisms of 
osteoarthritis (OA)-related pain. Studies have found 
diﬀ   ering degrees of association between radiographic 
changes and pain severity, but it is generally accepted 
that factors other than radiographic features contribute 
to pain levels. Damage or inﬂ  ammation of joint structures 
such as the synovial capusule, bursae, fat pad, ligaments, 
menisci, or adjacent bone may contribute to pain severity.
Th   ere is increasing recognition of the important role of 
central pain sensitivity, however, which is the focus of the 
recent paper by Murphy and colleagues in Arthritis 
Research and Th  erapy [1]. Th  e hypothesis is, and there 
are data to support, that chronic OA-related peripheral 
pain stimuli may lead to hyperexcitability of pain-
transmitting neurons [2]. Studies have shown that 
patients with OA do experience heightened pain 
sensitivity, with substantial intra-individual variability 
[2,3]. However, the vast majority of OA-related treat-
ments target the periphery; for example, nonsteroidal 
anti-inﬂ   ammatory drugs act on local inﬂ  ammatory 
processes. While these medications also aﬀ  ect  central 
pain mechanisms – either directly or indirectly through 
their inﬂ  uence on peripheral pain stimuli and sensitivity 
[4] – failure to more fully address central pain sensiti-
zation may be one reason for inadequate pain relief in 
some patients.
Th   e study by Murphy and colleagues provides 
additional support that patients diﬀ  er in the degree to 
which central mechanisms contribute to OA-related pain 
and other symptoms [1]. Th  e authors used a cluster 
analysis approach and identiﬁ   ed three subgroups of 
patients, one of which was characterized not only by the 
highest pain levels but also by other symptoms charac-
teristic of centrally mediated pain. Th   is is an interesting 
and clinically relevant approach to the question of central 
pain contribution, providing support to the notion that 
patients with greater central pain sensitivity could be 
identiﬁ   ed in routine care settings, without the use of 
formal pain threshold testing or other processes that 
would typically be utilized in research.
Given the mounting evidence for the importance of 
central pain sensitivity in OA [5], how can this be 
addressed in routine clinical care? Th  ere is certainly a 
need to further educate clinicians (and particularly those 
in primary care, who typically provide ﬁ  rst-line treatment 
for OA) about the important role of central pain 
adaptations, basic signs of central pain sensitivity, and the 
utility of current treatments to address this aspect of 
pain. Cognitive behavioral pain management interven-
tions have shown eﬃ   cacy for treating neuropathic pain, 
but these interventions are underutilized among patients 
with OA. Increased availability and use of these programs 
could be one practical step toward improving treatment 
of the central aspect of pain. Opioid analgesics act 
centrally and also have a role in OA treatment; despite 
their potential for adverse side eﬀ  ects, they may be an 
eﬀ   ective treatment for patients with a strong central 
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© 2011 BioMed Central Ltdcontribution to the pain experience. Th  ere is also some 
evidence for use of duloxetine and other antidepressants 
in the treatment of OA-related pain, and these therapies 
may be most eﬀ  ective for patients with greater central 
contributions to pain. More data are needed, however, to 
determine the appropriateness and eﬀ  ectiveness of these 
medications in the treatment of OA, as well as guidelines 
for when and how they are best applied in this patient 
group.
Murphy and colleagues and other researchers have 
suggested that OA treatment regimens could be tailored 
according to patients’ pain mechanisms (for example, 
relative contribution of peripheral vs. central contribu-
tions). Th   is suggestion certainly seems appealing both in 
terms of clinical eﬃ   ciency and likelihood of treatment 
response. However, there are at least two areas in which 
additional research is needed to support this tailored 
treatment becoming a clinical reality. First, additional 
research is needed to both identify new strategies and 
further evaluate existing therapies (including pharmaco-
logical and nonpharmaco  logical) that target central 
aspects of OA-related pain. Th  is area of treatment 
development has lagged con  siderably behind strategies to 
address peripheral aspects of pain. Second, brief and 
evidence-based strategies are needed to identify patients 
who have a stronger central component to OA-related 
pain. Th   e study by Murphy and colleagues suggests this 
further research is possible, and other studies – for 
example, that by Gwilym and colleagues [6] – have used 
surveys to identify patients with neuro  pathic pain 
symptoms. Th   e existing screening tools are probably too 
cumbersome for busy care providers, however, and 
simpler methods are needed for clinicians to readily 
identify patients who may beneﬁ  t more from treatments 
that target central pain mechanisms.
In summary, treatment of central pain sensitivity is an 
area with great promise for improving pain management 
in at least a subset of patients with OA; eﬀ  orts are clearly 
needed to expand the evidence base for both identi-
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